AKT1 and colorectal carcinoma: In contrast to the previously published study which showed no correlation between PI3K status and CRC cell lines sensitive to FASN inhibition [12], our data from analysis of cell lines and PDX models treated with TVB inhibitors suggest that PI3K mutational status and activation of Akt downstream may affect the response of CRC cells to FASN inhibition.